Biotech - Technical Analysis Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech - Technical Analysis

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (375)	5/9/2002 11:40:37 PM
From: Jibacoa	Read Replies (1) of 544

NPRO was the best performing Biotech today (up 44.53% on volume of 4,369,900 after it (in partnership with Abbott) received approval to sell an injectable form of paclitaxel. biz.yahoo.com However, in spite of its good up-gap today NPRO was not able to test the April 16 H of 9.48 (today's intra-day H was 9.36) and it still has to face the March 1 H at 11.70 before it can test the December H at 13.23 <g> siliconinvestor.com NPRO has also been underperforming the general market so far this year. siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next